Schrödinger is a leading provider of software solutions for drug discovery and development. The company's platform combines artificial intelligence, machine learning, and high-performance computing to help pharmaceutical companies find new drugs more quickly and efficiently. The platform includes a variety of tools and services, such as: * Molecular modeling: This tool allows scientists to visualize and simulate the structure and properties of molecules. * Drug design: This tool helps scientists design new drugs that are more likely to be effective and safe. * Virtual screening: This tool allows scientists to screen large libraries of molecules to find those that are most likely to bind to a target protein. * In vitro experiments: This tool allows scientists to test the effects of drugs in cells and animals. Schrödinger's platform has been used to discover and develop a number of new drugs, including: * Ibrutinib, a drug for treating chronic lymphocytic leukemia. * Venetoclax, a drug for treating chronic myeloid leukemia. * Olaparib, a drug for treating ovarian cancer.